InvestorsHub Logo
Followers 45
Posts 4461
Boards Moderated 0
Alias Born 03/20/2015

Re: Ready4bluesky post# 58401

Thursday, 04/07/2016 8:08:21 PM

Thursday, April 07, 2016 8:08:21 PM

Post# of 704240
Do you not understand the king's English?
Here is it is one more time Dr Prins verbatim:


30:37
I think that in conclusion immunotherapy is an exciting new field
It may likely be relevant for glioblastoma in the near future.
Although there are a lot of on going clinical trials going on right now
Not all glioblastomas are likely to be sensitive. I think t
There are some subtypes ahhh more likely to respond to an immune based therapy
We got to learn how to predict.
Some of these patients are likely to have incomplete tumor resections from the clinical side.
This is hard to treat because of the adaptive immune resistance that develops and combinatorial strategies are probably likely to be important.
The identification of patient specific neoantigens I am sure is going to be relevant.
The ability to be able to do it in a straight forward fashion that you can do it to make a difference for patients is really what the future is going to hold.
31:38


If you are going to ding me for not quoting verbatim then quote something verbatim that support your point
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News